More articles about: Cancer (Oncology)
Health Lab
Routine blood test leads to life saving osteosarcoma diagnosis
Mike Nagle’s osteosarcoma journey, before he even had symptoms, was nothing short of a miracle, he explains in this article.
Health Lab
New strides in Ewing sarcoma research
Patrick Grohar answers questions about symptoms, treatments and research initiatives that are being undertaken with respect to Ewing Sarcoma.
Philanthropy News
Block Out Cancer: Stand With Us to Make a Difference for Children
National Childhood Cancer Awareness Month in September spotlights the impact of pediatric cancer and emphasizes the vital roles of research and patient support programs.
Health Lab
Study sheds light on why some prostate tumors are resistant to treatment
A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Health Lab
Study reveals mechanisms behind common mutation and prostate cancer
A study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.
Philanthropy News
Annual 5K event builds awareness and support for rare cancer research
The Stomp Out Sarcoma 5K joins patients, survivors, care providers, and loved ones to raise funds and awareness for sarcoma research at the U-M Rogel Cancer Center.
Health Lab
Doctor helps one father’s race against lung cancer
Successful treatment of ALK-positive cancer is giving a patient hope for the future that includes trips around the motocross track and time with his wife and four kids.
News Release
$40 million gift supports Michigan Medicine’s new specialty care facility in Troy and mental health research
A $40 million gift to Michigan Medicine from the Eisenberg Foundation will be honored with the naming of a center for specialty care that will be built in Troy, and will support depression prevention research.
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
Cancer Aware
University of Michigan’s Impact on the Future of Cancer Care
Four University of Michigan faculty members have served as president of the American Society of Clinical Oncology, a rare distinction that only two other institutions can claim. ASCO is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
In this episode, Nicole Fawcett, director of communications for the Rogel Cancer Center, sat down with four past ASCO Presidents and talked about the importance of the society, the impact it has had on cancer care and research as a whole and the impact here at U-M.
Participants:
Allen Lichter, MD, FASTRO
Doug Blayney, MD
Dan Hayes, MD
Lori Pierce, MD
Health Lab
New clinical trials for pediatric brain tumors
Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.
Health Lab
Researchers engineer a herpes virus to turn on T cells for immunotherapy
The University of Michigan team identified herpesvirus saimiri, which infects the T cells of squirrel monkeys, as a source of proteins that activate pathways in T cells that are needed to promote T cell survival.
Health Lab
Researchers discover new protein target for childhood medulloblastomas
Group-3 medulloblastomas are aggressive and incurable, contributing to childhood cancer deaths. Led by University of Michigan researchers, a study identified a new target for Group-3 medulloblastomas. The results help identify new therapeutic avenues for treating these deadly tumors.
Health Lab
Interplay between key proteins could serve as a target for cancer treatment
University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.
Health Lab
Researchers identify roles of key genes in colon cancer development
Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.
